FITCHBURG, Mass., Oct. 23 /PRNewswire-FirstCall/ -- Integrated Pharmaceuticals, Inc. (IntePharm) announced today that effective October 10 the common shares of the Company have been accepted for quotation on the OTC Bulletin Board.
Dr. Chatterjee, president and CEO of the company, mentioned further that the company is in active discussion with several funding organization for implementing its business plan.
About IntePharm
IntePharm is an emerging producer of pharmaceuticals, specialty compounds for the pharmaceutical, nutraceutical and functional food and beverage industries. In addition to manufacturing products, IntePharm discovers and develops more efficient and cost-effective manufacturing and mineral delivery processes. These processes are developed using a comprehensive technology platform that combines metabolic engineering, cellular genetics, advanced bioprocess engineering, and computer simulation science. The company owns several other pending patents for new products and technologies for immediate commercialization in food and nutritional products market.
For further information please contact Dr. Chinmay Chatterjee, Integrated Pharmaceuticals, Inc. (IntePharm), at (978) 696-0020, or visit http://www.intepharm.com
Integrated Pharmaceuticals, Inc.CONTACT: Dr. Chinmay Chatterjee of Integrated Pharmaceuticals, Inc.,+1-978-696-0020
Web site: http://www.intepharm.com/
